ID: ALA388796

Max Phase: Preclinical

Molecular Formula: C40H74N12O9

Molecular Weight: 867.11

Molecule Type: Protein

Associated Items:

Representations

Canonical SMILES:  CC(C)C[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O

Standard InChI:  InChI=1S/C40H74N12O9/c1-22(2)18-28(48-32(53)21-46-37(58)31-14-11-17-52(31)38(59)26(42)12-10-16-45-40(43)44)35(56)51-29(19-23(3)4)34(55)47-25(7)33(54)50-30(20-24(5)6)36(57)49-27(39(60)61)13-8-9-15-41/h22-31H,8-21,41-42H2,1-7H3,(H,46,58)(H,47,55)(H,48,53)(H,49,57)(H,50,54)(H,51,56)(H,60,61)(H4,43,44,45)/t25-,26-,27-,28-,29-,30-,31-/m0/s1

Standard InChI Key:  VGDPWMHECVGJAE-XIJWKTHWSA-N

Associated Targets(non-human)

Hypothalamus (44 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 867.11Molecular Weight (Monoisotopic): 866.5702AlogP: -1.52#Rotatable Bonds: 28
Polar Surface Area: 346.15Molecular Species: ZWITTERIONHBA: 11HBD: 12
#RO5 Violations: 3HBA (Lipinski): 21HBD (Lipinski): 15#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.94CX Basic pKa: 11.61CX LogP: -3.69CX LogD: -6.68
Aromatic Rings: 0Heavy Atoms: 61QED Weighted: 0.02Np Likeness Score: 0.00

References

1. Rego JL, Leprince J, Luu-The V, Pelletier G, Tonon MC, Vaudry H..  (2007)  Structure-activity relationships of a series of analogs of the endozepine octadecaneuropeptide (ODN(11)(-)(18)) on neurosteroid biosynthesis by hypothalamic explants.,  50  (13): [PMID:17550241] [10.1021/jm0610548]

Source